Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 225

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study

Open access
Shi, Chen, Wang, Cong, Wang, Hanxiang, Yang, Chao, Cai, Fei, Zeng, Fang, Cheng, Fang, Liu, Yihui, Zhou, Taotao, Deng, Bin, Vlodavsky, Israel, Li, Jin‐Ping, Zhang, Yu · 2020 · Clinical and Translational Science

Published version of a preprint

Abstract

On March 11, 2020, the World Health Organization declared its assessment of coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) drugs are still under development, and patients are managed by multiple complementary treatments. We performed a retrospective analysis to compare and evaluate the effect of low molecular weight heparin (LMWH) treatment on disease progression. For this purpose, the clinical records and laboratory indicators were extracted from electronic medical records of 42 patients with COVID‐19 (21 of whom were treated with LMWH, and 21 without LMWH) hospitalized (Union Hospital of Huazhong University of Science and Technology) from February 1 to March 15, 2020. Changes in the percentage of lymphocytes before and after LMWH treatment were significantly different from those in the control group ( P = 0.011). Likewise, changes in the levels of D‐dimer and fibrinogen degradation products in the LMWH group before and after treatment were significantly different from those in the control group ( P = 0.035). Remarkably, IL‐6 levels were significantly reduced after LMWH treatment ( P = 0.006), indicating that, besides other beneficial properties, LMWH may exert an anti‐inflammatory effect and attenuate in part the “cytokine storm” induced by the virus. Our results support the use of LMWH as a potential therapeutic drug for the treatment of COVID‐19, paving the way for a subsequent well‐controlled clinical study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cts.12880

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. 10.1016/S0140-6736(20)30185-9 · DOI · Paper page
  2. 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  3. 10.1038/s41392-020-0127-9 · DOI · Paper page
  4. 10.1038/s41392-020-0148-4 · DOI · Paper page
  5. 10.4049/jimmunol.169.8.4288 · DOI · Paper page
  6. Wan S.X.et al.Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) [preprint](2020). https://doi.org/https://doi.org/10.1101/2020.02.10.20021832. Posted on MedRxiv. February 12 2020. · DOI · Paper page
  7. 10.1186/s40425-018-0343-9 · DOI · Paper page
  8. 10.2217/imt-2016-0020 · DOI · Paper page
  9. 10.3109/15412555.2013.831062 · doi:10.3109/15412555.2013.831062
  10. 10.1016/j.jss.2019.01.020 · DOI
  11. Li X., 2016, Unfractionated heparin inhibits lipopolysaccharide‐induced expression of chemokines in human endothelial cells through nuclear factor‐κB signaling pathway, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 28, 117
  12. Rao D., 2014, Research progress on cytokine storm induced by pathogen infection, Med. Informat., 27, 480
  13. 10.4049/jimmunol.165.10.5671 · DOI · Paper page
  14. 10.1146/annurev.biochem.68.1.729 · DOI · Paper page
  15. 10.1101/cshperspect.a004952 · DOI · Paper page
  16. 10.1111/jth.14933 · doi:10.1111/jth.14933
  17. 10.1152/ajplung.00199.2020 · DOI · Paper page
  18. 10.1172/JCI200113530 · doi:10.1172/jci200113530 · Paper page
  19. 10.1038/nm0897-866 · DOI · Paper page
  20. 10.1172/JCI200113799 · DOI
  21. 10.1128/JVI.01933-17 · DOI · Paper page
  22. Mycroft‐West D. S.et al.The 2019 coronavirus (SARS‐CoV‐2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding [preprint](2020). https://doi.org/https://doi.org/10.1101/2020.02.29.971093. Posted on BioRxiv. March 2 2020. · DOI · Paper page
  23. 10.1111/j.1440-1797.2008.01012.x · doi:10.1111/j.1440-1797.2008.01012.x
  24. 10.2174/138161207781039742 · DOI · Paper page
  25. 10.1038/ncomms7985 · DOI
  26. 10.1016/j.virol.2019.01.001 · doi:10.1016/j.virol.2019.01.001
  27. 10.1016/j.celrep.2017.06.041 · DOI
  28. 10.1371/journal.ppat.1006673 · DOI · Paper page
  29. 10.1016/j.ijid.2020.03.053 · DOI · Paper page
  30. 10.1097/01.CCM.0000059441.70680.DC · DOI
  31. 10.1111/jth.14768 · DOI · Paper page
  32. 10.1378/chest.126.4.1087 · doi:10.1378/chest.126.4.1087
  33. 10.1016/j.ejim.2011.10.019 · DOI
  34. Duarte J.C., 2015, Prognostic value of plasma D‐dimer level in adults with community‐acquired pneumonia: a prospective study, Rev. Port. Pneumol. (2006), 21, 218

Cited by

See all 225

Metadata

Authors
Shi, C., Wang, C., Wang, H., Yang, C., Cai, F., Zeng, F., Cheng, F., Liu, Y., Zhou, T., Deng, B., Vlodavsky, I., Li, J., & Zhang, Y.
Venue
Clinical and Translational Science
Publisher
Wiley
Published
2020-10-15
Volume
13
Issue
6
Pages
1087-1095
ISSN
  • 1752-8054 (ISSN-L)
  • 1752-8062
OpenAlex
W3082558676
Cited by
225
References
6
FWCI
6.07
Type
journal article
Language
en
Open access
gold
Funders
  • Research and Development (2017YFC0909900)
  • National Natural Science Foundation of China (81603037)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.